Saxonov Serge's Form 4 filing
10x Genomics, Inc. (TXG) · filed Jan 6, 2022
- Accession no.
- 0001567619-22-000817
- Filed
- Jan 6, 2022
- Trade date
- Jan 4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.12M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saxonov SergeCIK 0001786720 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Class A Common Stock | MOption exerciseAcquired | +3,037 | $11.48 | +$34,864.76 | 937,255 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −1,000 | $138.86F2 | −$138,860 | 936,255 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −3,100 | $139.82F3 | −$433,442 | 933,155 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −5,368 | $140.96F4 | −$756,673.28 | 927,787 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −2,932 | $141.72F5 | −$415,523.04 | 924,855 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −700 | $143.11F6 | −$100,177 | 924,155 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −1,400 | $144.78F7 | −$202,692 | 922,755 | Direct | |
| Jan 4, 2022 | Class A Common Stock | SSaleDisposed | −500 | $145.33F8 | −$72,665 | 922,255 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Class A Common Stock | MOption exerciseDisposed | −3,037 | $0.00 | $0 | 45,559 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $138.29 to $139.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $139.33 to $140.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $140.38 to $141.375. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $141.38 to $142.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $142.99 to $143.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $144.185 to $145.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $145.19 to $145.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.